Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.35 |
| ▸ | RCOR1 | Q9UKL0 | 1/20 | 0.35 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.31 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.31 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.31 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.31 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.31 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.31 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.31 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22206929 | 0.89 | KDM4E (0.32) | KDM4E | |
| SCHEMBL29378781 | 0.86 | LMNA (0.33) | CYP1A2SMN1; SMN2KDM4ELMNA | |
| SCHEMBL28339120 | 0.82 | OPRM1 (0.41) | KDM4ELMNAL3MBTL1 | |
| SCHEMBL6562524 | 0.81 | CYP1A2 (0.39) | CYP1A2KDM1ARCOR1PSEN1PSEN2 | |
| SCHEMBL30773034 | 0.81 | TSHR (0.35) | PTGS2LMNAGAAL3MBTL1 | |
| SCHEMBL23395048 | 0.79 | NOTUM (0.37) | SMN1; SMN2LMNA | |
| SCHEMBL26033534 | 0.76 | L3MBTL1 (0.33) | KDM4ELMNAL3MBTL1 | |
| SCHEMBL22268392 | 0.74 | — | — | |
| SCHEMBL6037214 | 0.72 | OPRM1 (0.32) | HSD11B1LMNAGAAL3MBTL1 | |
| SCHEMBL26824895 | 0.71 | CCR2 (0.34) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11545630-B2 | Compound and organic electroluminescent device comprising the same | LG DISPLAY CO., LTD. (KR) | 2023-01-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11545630-B2 | Compound and organic electroluminescent device comprising the same | PIEZO1, KCNN2, ORAI2 | CYP1A2 1643/4885KDM1A 2652/4885RCOR1 1925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.